WOLVERINE ASSET MANAGEMENT LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 136 filers reported holding NEKTAR THERAPEUTICS in Q2 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2020$424,000
+731.4%
25,587
+1046.4%
0.00%
+300.0%
Q2 2020$51,000
-23.9%
2,232
-50.4%
0.00%0.0%
Q4 2014$67,000
+15.5%
4,5010.0%0.00%0.0%
Q3 2014$58,0004,501
+37408.3%
0.00%
Q2 2014$012
+1100.0%
0.00%
Q1 2014$0
-100.0%
1
-98.1%
0.00%
Q3 2013$3,000
-97.4%
52
-99.4%
0.00%
-100.0%
Q2 2013$116,0008,8990.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2013
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders